ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Advanced Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study of Participants With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3